Press Releases - 2023-12-11

Date	Title	Company
11-Dec-2023	Atara Biotherapeutics Presents Positive Preclinical Data on ATA3431, A Next-Generation Allogeneic CD20/CD19-Targeted CAR, at the 65th ASH Annual Meeting	Businesswire
11-Dec-2023	MedinCell: Videoconference and Publication of Half-year Financial Results, Tuesday, December 19th, 2023	Businesswire
11-Dec-2023	MEI Pharma Reports Clinical Data on Oral CDK9 Inhibitor Voruciclib at ASH2023	Businesswire
11-Dec-2023	Gilead Named to Dow Jones Sustainability World Index for Third Consecutive Year	Businesswire
11-Dec-2023	Data Analytics in Medical Devices Thematic Intelligence Report 2023: AI-Native Vendors Take Center Stage - ResearchAndMarkets.com	Businesswire
11-Dec-2023	Patient Advocacy and Community Engagement at Alkermes	AccessWire
11-Dec-2023	Global Internet of Things (IoT) in Healthcare Thematic Intelligence Report 2023 - ResearchAndMarkets.com	Businesswire
11-Dec-2023	Kramer Levin Elevates Five to Counsel and Three to Special Counsel	Businesswire
11-Dec-2023	Middle East & Africa Construction Industry Report 2023: Saudi Arabia is Projected to be at the Forefront of Investments - ResearchAndMarkets.com	Businesswire
11-Dec-2023	MasterWord Makes Connecting With Healthcare Interpreters Easy With Epic Integration	AccessWire
11-Dec-2023	Daido Steel Accelerates Materials Design and Qualification with ICMD® SaaS Platform from QuesTek	Businesswire
11-Dec-2023	Corsair Pharma Announces Appointment of George W. Mahaffey as Chief Executive Officer	Businesswire
11-Dec-2023	Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium	Businesswire
11-Dec-2023	Glycomine Announces First Pediatric Patient Dosed in Phase 2 Clinical Study of GLM101, a Potential Treatment for PMM2-CDG	Businesswire
11-Dec-2023	Aptar Pharma Continues Global Expansion Program with Opening of New Mumbai Site	Aptar Pharma
11-Dec-2023	Pharmaceuticals and life sciences jobs halved in the last year while applications nose-dive	Association of Professional Staffing Companies (APSCo)
11-Dec-2023	Puma Biotechnology Announces Phase II Clinical Trial Design for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer	Businesswire
11-Dec-2023	POLB 001 – targeting Cytokine Release Syndrome (CRS) associated with cancer immunotherapies	Poolbeg Pharma plc
11-Dec-2023	New Data Presented at ASH from the Phase 3 GLOW Study Show Fixed-Duration, First-Line Treatment with IMBRUVICA® (ibrutinib) Plus Venetoclax Demonstrated an Overall Survival Rate of More Than 84 Percent at 54 Months in Patients with Chronic Lymphocytic Leukaemia	Jassen
11-Dec-2023	NovalGen presents NVG-111 clinical data in hematological malignancies in an oral session and preclinical data for next-generation AR T cell engager NVG-222 at the 65th American Society of Hematology Annual Meeting	NovalGen